Title : Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.

Pub. Date : 2015 Apr

PMID : 26182309






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 IMPORTANCE: The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is effective in patients with chronic lymphocytic leukemia (CLL). ibrutinib Bruton tyrosine kinase Homo sapiens
2 IMPORTANCE: The Bruton tyrosine kinase (BTK) inhibitor ibrutinib is effective in patients with chronic lymphocytic leukemia (CLL). ibrutinib Bruton tyrosine kinase Homo sapiens